EU Business Round-Up: EA Pharma Acquires Drasanvi, Bios Line Attracts Investment, Diapharm Sets Up Swiss Office

The latest European consumer health business news: France's EA Pharma snaps up Spain's Drasanvi; Italy's Bios Line attracts minority investment; and Diapharm sets up in Switzerland to help device manufacturers.

France’s EA Pharma is set to expand its offering in Europe’s food supplements and cosmetics markets by acquiring the Drasanvi Group for an undisclosed sum.

Spain’s Drasanvi enjoyed a “unique and valuable position in the nutraceutical and health nutrition sector,” EA Pharma claimed, offering a wide range of products, based on rigorously selected ingredients.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography